← Eichor
Condition: Solid Organ Malignancies Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Solid Organ Malignancies

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Host Genome Methylation: a Screening Tool in Anal Cancer Detection
NA · 9 location(s) · Assistance Publique - Hôpitaux de Paris · NCT06792604A First-In Human (FIH) Study to Find Out How Well REGN10597 Medicine Given Alone or in Combination With Cemiplimab Works
Phase 1/Phase 2 · 11 location(s) · Regeneron Pharmaceuticals · NCT06413680Rapid Processing and Immunohistochemistry Method for Optimising Diagnosis Time in Solid Organ Donors, Suspected Malignan
NA · 1 location(s) · IRCCS Azienda Ospedaliero-Universitaria di Bologna · NCT06734091Central-boost Ablative Radiation Therapy for Solid Tumors (CBART)
Phase 2 · 1 location(s) · Changhai Hospital · NCT06427460Neural Network-based Treatment Decision Support Tool in Patients With Refractory Solid Organ Malignancies
Phase 2 · 1 location(s) · National University Hospital, Singapore · NCT05719428Molecular Prediction of Development, Progression or Complications of Kidney, Immune or Transplantation-related Diseases
Phase N/A · 1 location(s) · University Hospital, Toulouse · NCT05318196A Platform Study for solId orgaN CancERs
Phase N/A · 1 location(s) · University of Liverpool · NCT05650125High Dose Re-Irradiation Utilizing Advanced Deformable Image Registration (DIR) and Individualized Organ At Risk (OAR) D
NA · 1 location(s) · Medical College of Wisconsin · NCT05301101Nicotinamide Chemoprevention for Keratinocyte Carcinoma in Solid Organ Transplant Recipients - Pivotal Trial
Phase 3 · 7 location(s) · Women's College Hospital · NCT05955924A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative
Phase 3 · 71 location(s) · Pierre Fabre Medicament · NCT03394365Study of Aerosol Gemcitabine in Patients With Solid Tumors and Pulmonary Metastases
Phase 1 · 1 location(s) · M.D. Anderson Cancer Center · NCT03093909Evaluation of Safety and Efficacy of Autologous LB-DTK-CMV in Patients With Antiviral-Resistant and Refractory Cytomegal
NA · 1 location(s) · LucasBio · NCT07679412The Organ Transplant Recipient HPV and Skin Cancer Study
Phase N/A · 3 location(s) · Merete Haedersdal · NCT05284877BZLF1 Peptide Vaccine (OSU-2131) With QS-21 for the Prevention of Epstein-Barr Virus Related Cancer in Patients Awaiting
Phase 1 · 1 location(s) · Ohio State University Comprehensive Cancer Center · NCT06741072Viral Specific T-Lymphocytes to Treat Infection With Adenovirus, Cytomegalovirus or Epstein-Barr Virus in Patients With
Phase 1/Phase 2 · 3 location(s) · Jessie L. Alexander · NCT06909110
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.